FDA updates in urology: May 2025

Welcome to Urology Times’® monthly FDA update! In May, key developments included 2 FDA Advisory Committee meetings on upcoming regulatory decisions, movement of a point-of-care men’s sexual health test into FDA review, and advancement of CAN-2409 along its regulatory pathway for localized prostate cancer.